← FDA Drug Approvals (Drugs@FDA)
MIDAZOLAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2022-11-01
Drug application
- FDA Application #
ANDA216048- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIDAZOLAM
- Generic name
- Midazolam
- Active ingredients
- MIDAZOLAM
- Dosage form
- SPRAY
- Route
- NASAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- CIPLA LTD
- First approval
- 2022-11-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown